Ractigen Therapeutics

  • Ractigen Therapeutics completed RMB 100mln in Series A financing, led by GL Ventures

    Ractigen Therapeutics announced today that it has completed 110 million yuan in Series A financing. This round of financing was led by GL Ventures, with participation from CCBI Healthcare Growth Fund, Chongqing Boyi Equity Investment Fund Management, and Longmen Capital. The funds raised will be mainly used for R&D, team expansion, and investigational new drug (IND) application for multiple new drugs in the preclinical stage. RNA activation (RNAa) is a biological mechanism discovered and named for the first time in the world in 2006 by Dr. Long-Cheng Li, the founder…